Immucell Corp (ICCC) Reports Q3 EPS of $0.09
Tweet
Share
E-mailGet Alerts ICCC Hot Sheet
Join SI Premium – FREE
Immucell Corp (NASDAQ: ICCC) reported Q3 EPS of $0.09, versus $0.04 reported last year. Revenue for the quarter came in at $2.7 million, versus $2.21 million reported last year.
For earnings history and earnings-related data on Immucell Corp (ICCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Immucell Corp (ICCC) Reports Q2 EPS of $0.20
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
- Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
